SAM
JAZZ icon

Simplify Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Simplify Asset Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.5M Buy
68,560
+16,830
+33% +$3.69M 0.23% 21
2026
Q1 		$9.78M Sell
51,730
-19,448
-27% -$3.4M 0.15% 20
2025
Q4 		$12.1M Buy
+71,178
New +$10.9M 0.2% 20

Other funds holding JAZZ

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
ACM
Argent Capital Management St Louis, Missouri $3.17B AUM 36.16% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
PL
Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
BCM
BTC Capital Management Des Moines, Iowa $1.65B AUM 27.85% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
BC
Burney Company Reston, Virginia $3.71B AUM 37.66% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
OLA
Oliver Luxxe Assets Gladstone, New Jersey $680M AUM 47.51% 1-Year Est. Return

Simplify Asset Management's JAZZ Position: Q2 2026 in Review

Simplify Asset Management increased its Jazz Pharmaceuticals (JAZZ) stake by 33% in Q2 2026, buying an estimated $3.69M and bringing the position to 68,560 shares worth $16.5M. The position accounts for 0.23% of the portfolio, ranked #21.

Simplify Asset Management first reported a position in JAZZ in Q4 2025 and has held it in 3 quarters since. 69 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Simplify Asset Management held 68,560 shares of Jazz Pharmaceuticals worth $16.5M as of Q2 2026.
  • Simplify Asset Management bought 16,830 Jazz Pharmaceuticals shares in Q2 2026, an estimated $3.69M.
  • Jazz Pharmaceuticals made up 0.23% of Simplify Asset Management's portfolio in Q2 2026, its #21 holding.
  • Simplify Asset Management first reported a position in Jazz Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 69 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Simplify Asset Management's 13F filing for Q2 2026, filed 16 Jul 2026.